scispace - formally typeset
A

Anca Tilea

Researcher at University of Michigan

Publications -  32
Citations -  4967

Anca Tilea is an academic researcher from University of Michigan. The author has contributed to research in topics: Kidney disease & Population. The author has an hindex of 14, co-authored 24 publications receiving 3981 citations.

Papers
More filters
Journal ArticleDOI

US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States

TL;DR: Author(s): Saran, Rajiv; Robinson, Bruce; Abbott, Kevin C; Agodoa, Lawrence YC; Ayanian, John; Balkrishnan, Rajesh; Bragg-Gresham, Jennifer; Cao, Jie; Chen, Joline LT; Cope, Elizabeth; Dharmarajan, Sai; Dietrich, Xue; Eckard, Ashley; Eggers, Paul W; Gaber, Charles; Gillen, Daniel;
Journal ArticleDOI

US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.

TL;DR: Author(s): Saran, Rajiv; Robinson, Bruce; Abbott, Kevin C; Agodoa, Lawrence YC; Bragg-Gresham, Jennifer; Balkrishnan, Rajesh; Bhave, Nicole; Dietrich, Xue; Ding, Zhechen; Eggers; Gaipov, Abduzhappar; Gillen, Daniel; Gipson, Debbie; Gu, Haoyu; Guro, Paula; Haggerty, Diana
Journal ArticleDOI

US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States

TL;DR: Author(s): Saran, Rajiv; Robinson, Bruce; Abbott, Kevin C; Agodoa, Lawrence YC; Bhave, Nicole; Bragg-Gresham, Jennifer; Balkrishnan, Rajesh; Dietrich, Xue; Eckard, Ashley; Eggers, Paul W; Gaipov, Abduzhappar; Gillen, Daniel; Gipson, Debbie; Hailpern, Susan M; Hall, Yoshio N.
Journal ArticleDOI

Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States

TL;DR: Among patients with ESKD and AF on dialysis, apixaban use may be associated with a lower risk of major bleeding compared with warfarin, with a standard 5 mg twice a day dose also associated with reductions in thromboembolic and mortality risk.